BullFrog AI Holdings BFRG
NASDAQ BFRG
$0.50 +0.01 (+2.04%)
At close: Sep 4, 2026 · 4:00 PM EDT

BullFrog AI Holdings (BFRG) Non Operating Income (2022 - 2026)

BullFrog AI Holdings' (BFRG) quarterly Non Operating Income came in at $47531.0 in Q2 2026, up 126.94% on a YoY basis from $20944.0 in Q2 2025, and up 157.12% quarter-over-quarter from $18486.0 in Q4 2025.

Analysis

BullFrog AI Holdings (BFRG) Non Operating Income (2022 - 2026) Analysis & Trends

BullFrog AI Holdings (BFRG) has reported Non Operating Income for 5 consecutive years, with $47531.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non Operating Income rose 126.94% year-over-year to $47531.0; the trailing twelve-month figure through Jun 2026 stood at $105032.0 (down 38.4% YoY), and the FY2025 full-year result was $96568.0, down 60.22% from the prior year.
  • Non Operating Income rose to $47531.0 in Q2 2026 per BFRG's latest filing, from $18486.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $70317.0 in Q2 2024 and bottomed at -$134902.0 in Q1 2023.
  • Historically, Non Operating Income has averaged $3047.3 across 5 years, with a median of $38819.0 in 2023.
  • The widest YoY moves for Non Operating Income: up 160.21% in 2023, down 737.48% in 2023.
  • Over 5 years, Non Operating Income stood at -$112475.0 in 2022, then soared by 134.51% to $38819.0 in 2023, then surged by 39.15% to $54018.0 in 2024, then slumped by 65.78% to $18486.0 in 2025, then surged by 157.12% to $47531.0 in 2026.
  • According to Business Quant data, Non Operating Income over the past three periods registered $47531.0, $18486.0, and $18071.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -73.00 Mn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 387.00 Mn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 234.30 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -53.64 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -
10 BullFrog AI Holdings 9.27 Mn 2.35 Mn 106,899.00 47,531.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 47,531.00
Dec 31, 2025 18,486.00
Sep 30, 2025 18,071.00
Jun 30, 2025 20,944.00
Mar 31, 2025 39,067.00
Dec 31, 2024 54,018.00
Sep 30, 2024 56,477.00
Jun 30, 2024 70,317.00
Mar 31, 2024 61,924.00
Dec 31, 2023 38,819.00
Sep 30, 2023 51,166.00
Jun 30, 2023 56,572.00
Mar 31, 2023 -134,902.00
Dec 31, 2022 -112,475.00
Sep 30, 2022 -124,141.00
Jun 30, 2022 -93,962.00
Mar 31, 2022 -16,108.00